P. Můčková

Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS

P. Andersen, W. Robberecht, F. Salachas, 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease

O. Witte, R. Vandenberghe, P. van Damme, 2017, Neurology.

A next generation setup for pre-fractionation of non-denatured proteins reveals diverse albumin proteoforms each carrying several post-translational modifications

J. Grosskreutz, H. Rhode, Michael W Vogel, 2019, Scientific Reports.

The intricacy of biomarker complexity–the identification of a genuine proteomic biomarker is more complicated than believed

J. Grosskreutz, H. Rhode, P. Můčková, 2016, Proteomics. Clinical applications.

Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine

W. Schrödl, H. Rhode, P. Reinhold, 2016, Proteomics. Clinical applications.

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

F. Salachas, P. van Damme, M. Amador, 2018, Neurology.

Preclinical Alterations in the Serum of COL(IV)A3(-)/(-) Mice as Early Biomarkers of Alport Syndrome.

D. Rubel, O. Gross, H. Rhode, 2015, Journal of proteome research.

Proteomic biomarkers for psoriasis and psoriasis arthritis.

J. Norgauer, T. Krüger, H. Rhode, 2016, Journal of proteomics.

Proteomic biomarkers for psoriasis and psoriasis arthritis.

H. Rhode, S. Nemitz, P. Můčková, 2016, Journal of proteomics.